A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this clinical study is to find out which zenagamtide dose can be switched to, from maintenance dose of tirzepatide in people with overweight or obesity, with or without type 2 diabetes (T2D). All participants will get tirzepatide and zenagamtide.
Epistemonikos ID: 034e5afc7815bc2fb5d30a829abb8208ac0017ed
First added on: Oct 10, 2026